serine has been researched along with sertraline in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ben-Shushan, G; Gil-Ad, I; Hershkovitz, A; Isaac, R; Levkovitz, Y; Ronen, D; Shvartsman, D; Weizman, A; Zick, Y | 1 |
| Cammue, BPA; Cassiman, D; De Brucker, K; De Cremer, K; De Keersmaecker, K; Fendt, SM; Geeraerts, SL; Gupta, P; Heylen, E; Kampen, KR; Louros, N; Planque, M; Rinaldi, G; Rousseau, F; Schymkowitz, J; Thevissen, K; Verbelen, B; Vereecke, S; Vermeersch, P; Voet, A | 1 |
2 other study(ies) available for serine and sertraline
| Article | Year |
|---|---|
Antidepressants induce cellular insulin resistance by activation of IRS-1 kinases.
Topics: Animals; Cell Line, Tumor; Diabetes Mellitus; Enzyme Activation; Insulin; Insulin Receptor Substrate Proteins; Insulin Resistance; JNK Mitogen-Activated Protein Kinases; Metabolic Syndrome; Paroxetine; Phosphoproteins; Phosphorylation; Protein Serine-Threonine Kinases; Rats; Selective Serotonin Reuptake Inhibitors; Serine; Sertraline; Signal Transduction | 2007 |
Repurposing the Antidepressant Sertraline as SHMT Inhibitor to Suppress Serine/Glycine Synthesis-Addicted Breast Tumor Growth.
Topics: Animals; Antidepressive Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Drug Repositioning; Female; Glycine; Glycine Hydroxymethyltransferase; Humans; Mice, Inbred NOD; Mice, SCID; Molecular Docking Simulation; Phosphoglycerate Dehydrogenase; Serine; Sertraline; Thimerosal | 2021 |